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The thesis entitled 
 
“Cinnamide/Naphthalimide/Chalcone/Pyrazoline Hybrides as Potential Anticancer 
Agents and Quinoline Derivatives as Antimicrobial Agents” has been divided into four 
chapters. 
Chapter-I: General introduction of Cancer, Tubulin and Tuberculosis  
Cancer is a class of diseases or disorders characterized by uncontrolled/ abnormal 
division of cells and the ability of these to spread, either by direct growth into adjacent tissue, 
or by implantation into distant sites by metastasis, in which cancer cells are transported 
through the bloodstream or lymphatic system. Small molecules that disrupt 
microtubule/tubulin dynamics are used widely in cancer treatment. Hence discovery and 
development of new small molecules useful in cancer chemotherapy has identified tubulin as 
possible molecular target medicinal chemists for past few years. Microtubules are one of the 
key structural components of the cytoskeleton in eukaryotic cells comprising of α and β-
tubulin heterodimers. They play a crucial role in various cellular processes and have emerged 
as an attractive and viable target in the development of anticancer drugs mainly due to their 
indispensability in mitotic cell division.  
Tuberculosis (TB) is an ancient, contagious disease caused by the pathogen 
Mycobacterium tuberculosis (M. tb) and is responsible for more human deaths than any other 
single infectious disease. According to World Health Organization (WHO), TB has become a 
more prevalent chronic disease causing 2-3 million deaths annually and infecting one third of 
the world population. Its deadly synergy with HIV has further aggravated the mortality and 
spread of this disease. In recent years, chemotherapy of TB has evolved in due course of 
time. Though there are many drugs available for the treatment of TB the emergence of 
resistance such as multi drug resistance (MDR) and extensive drug resistance (XDR) pose 
threat to the human life. Advances in research such as genetic engineering of M. tb have 
offered many validated targets to develop chemical libraries that may eventually lead to new 
drugs to combat TB. 
Statement of Problem 
Chapter-II: Arylcinnamido-Propionone Hybrids as Tubulin Polymerization Inhibitors 
and Apoptotic inducers. 
Cinnamides are another class of anticancer agents, its natural analogues are known for 
the treatment of cancer for over centuries. Phenylcinnamides are shown to bind to tubulin, 
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thereby causing an inhibition of its polymerization and alteration in the tubulin-microtubule 
equilibrium. They are known to possess an α,β-unsaturated carbonyl moiety, which can be 
considered as a Michael acceptor, employed as a powerful tool in the design of antimitotic 
agents. Some of the potent hybrid/conjugate molecules that have been recently developed as 
new anticancer agents are obtained by the combination of different pharmacophores.
 
Structural features of designed molecules, including the trimethoxyphenyl moiety (found in 
colchicine and 8H), suggested that these molecules exerted cytotoxic action through 
microtubule binding and mitotic arrest. Based on these observations we describe 
modifications on 8H scaffold which contain trimethoxyphenyl moiety without disturbance 
and further congeners were generated by conjugates with substituted arylpropynones to 
cinnamide scaffolds. In this context, we have designed, synthesized some newer cinnamido-
propionone conjugates and evaluated them for their cytotoxic potential apart from their effect 
on the inhibition of tubulin polymerization. 
 
Scheme: Synthesis of arylcinnamido-propionone hybrids 
 
Reagents and Conditions: (a) (i) (COCl)2, dry DCM, 0 °C to rt, 3 h; (ii) Trimethoxy aniline, 
Et3N, dry THF, 3 h; 69−71%; (b) Zn, HCO2NH4, MeOH, rt, 6 h; 60−70%; c) 
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ethynylmagnesium bromide, THF, 0°C−rt, 8−9 h; (d) 2-iodoxybenzoic acid, DMSO, rt, 5 h, 
73−88%; (e) EtOH, 3-4 h; 76−88%. 
Results and discussions 
A series of arylcinnamido-propionone conjugates (7-9a-h and 10a-f) has been 
designed, synthesized and evaluated for their anticancer potential against the four human 
cancer cell lines. Among them, conjugates 9d and 9g have showed significant cytotoxic 
activity against prostate cancer cells (DU-145) displaying IC50 of 7.48 and 8.91 µM 
respectively. Studies to understand the mechanism of action of 9d and 9g indicates that 
inhibit the tubulin polymerization thereby arresting the cell cycle in G2/M phase. 
Furthermore, studies like mitochondrial membrane potential and Annexin V-FITC assay 
suggested that these conjugates 9d and 9g induced cell death by apoptosis. The molecular 
docking studies suggested that the binding of these conjugates at the colchicine site of the 
tubulin protein. 
Conclusions 
Cinnamido-propionone conjugates (7-9a-h and 10a-f) were synthesized and evaluated 
for their cytotoxic activity. Conjugates 9d and 9g showed significant cytotoxic activity 
against human prostate cancer cell line, (DU-145). The flow cytometric analysis revealed that 
these conjugates cause cell cycle arrest at G2/M phase. Furthermore, they effectively 
inhibited microtubule assembly. Moreover, the triggering of the apoptotic cell death after 
mitotic arrest was investigated by mitochondrial membrane potential and Annexin V FITC 
assays suggest that these conjugates induced apoptosis. The molecular modeling study carried 
out on the colchicine binding site of tubulin demonstrated that these molecules are involved 
in a series of interactions with the protein thereby binding well with the tubulin. Therefore, 
the work reported herein could be considered of significant importance to provide valuable 
insights in the development newer leads for the treatment of cancer. 
Statement of Problem 
Chapter IIIA: Naphthalimide-Amidobenzothiazole and Naphthalimide-Cinnamide 
Hybrids as Potential Anticancer Agents. 
Naphthalimides represent an important chemical class of DNA-intercalating 
topoisomerase II inhibitors. These agents consist of flat chromophores, generally π-deficient 
aromatic or hetero aromatic system, which binds to DNA by insertion between the base pairs 
of the double helix. They are also characterized by the presence of basic side chains attached 
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to the chromophore. Charge transfer and stacking interactions are the main driving forces for 
binding. Intercalation causes the base pairs to separate vertically, thereby distorting the sugar 
phosphate backbone and changing the degree of rotation between successive base pairs, and 
finally disrupts the cell division. The most potent drugs in this series were amonafide and 
mitonafide both tested in humans as anticancer agents. Amonafide, a 5-amino substituted 
naphthalimide is a novel inhibitor of Topo II that intercalates into DNA and induces apoptotic 
signalling by blocking Topo II binding to DNA. To improve therapeutic properties of 
naphthalimides extensive efforts have been made including the modification of side chain, 
aromatic ring system, and the substituents on the ring. The promising biological activity 
exhibited by these naphthalimides prompted us to develop some newer hybrid molecules by 
linking the naphthalimide pharmacophore with aminobenzothiazole and cinnamide scaffold 
with a view to enhance their anticancer activity. Thus a library of twenty three new class of 
naphthalimide-amidobenzothiazole, naphthalimide-cinnamide hybrids were designed, 
synthesized and evaluated for their anticancer potential.  
Scheme: Synthesis of naphthalimide-amidobenzothiazole and naphthalimide-cinnamide 
hybrids 
 
Reagents and Conditions: (a) EtOH, Reflux, 60°C, 3h; (b) 2-bromoethyl acetate, K2CO3, 
DMF, 24 h;  (c) LiOH, THF, H2O, 12 h; (d) Substituted benzothiazoles, EDCI, HOBt, 
CH2Cl2, 24 h; (e) Substituted cinnamic acids, EDCI, HOBt, CH2Cl2, 24 h. 
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Results and discussions 
These conjugates (4a-g, 5a-b and 6a-n) were synthesized and evaluated for their 
antiproliferative activity against NCI-60 Cell line panel. Among them 5a and 5b showed 
remarkable growth inhibition on all the tested cell lines with GI50 values in the range of 
activity ranging 1.38-43.1 μM and 1.19-14.1 μM respectively. Initial DNA interaction studies 
of these compounds (by CD, UV/vis, and the fluorescence spectroscopy) expectedly 
suggested the π-π stacking interactions facilitate DNA intercalation activity. Furthermore, 
representative compounds were proved to possess strong inhibition against topoisomerase II. 
Therefore DNA and topoisomerase are the main targets of the agents. 
Conclusions 
A series of new naphthalimides were designed and synthesized and their cytotoxic 
activities were evaluated in vitro. Majority of these naphthalimides potentially inhibited the 
growth of HT-29, A549 cancer cell lines selectively. Interestingly hybrid compounds 5a, 5b 
that have an amide bond at 6-position displayed promising cytotoxic activity than reference 
drug amonafide. We were also investigated antitumor mechanism of action of 5a and 5b. The 
most active compounds potentially inhibit topo II. Moreover DNA interaction of the 
representative compounds was studied by CD spectra, UV-Visible Spectra and fluorescence 
spectra. Studies   demonstrating that these compounds intercalate with DNA. 
Statement of Problem 
Chapter IIIB: Chalcone/Pyrazoline based 2-(4-aminophenyl) benzothiazole Hybrids as 
Potential Anticancer Agents. 
Chalcones (3-diaryl-2-propen-1-ones) are biosynthetic products of the shikimate 
pathway, belonging to flavanoid family is precursors of open chain flavonoids and 
isoflavonoids, which are abundant in edible plants. Chalcones are also key precursors in the 
synthesis of many biologically important heterocycles such as benzothiazepine, pyrazolines, 
1,4-diketones, and flavones. Chemically, they consist of open chain flavanoids in which the 
two aromatic rings are joined by a three carbon α, β- unsaturated carbonyl system. Chalcones 
and pyrazolines have attracted increasing attention due to numerous pharmacological 
applications. They have displayed a broad spectrum of pharmacological activities, among 
which antimalarial, anticancer, antiprotozoal (antileishmanial and antitrypanosomal), anti-
inflammatory, antibacterial, antifilarial,
 
antifungal, antimicrobial, anticonvulsant and 
antioxidant activities have been reported. Similarly 2‐(4‐aminophenyl)benzothiazoles 
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constitute a new and simple class of antitumor molecules possessing diverse biological 
properties. These biologically active conjugates further encouraged to synthesize some newer 
conjugates that are likely to enhance the anticancer activity. In this context we designed and 
synthesized some new chalcone/pyrazoline-2-(4-aminophenyl) benzothiazole conjugates 15-
16(a-f) as potential anticancer agents.  
Scheme: Synthesis of chalcone/pyrazoline based 2-(4-aminophenyl) benzothiazole 
hybrids 
 
Reagents and conditions: (a) aq. KOH, ethanol, 6h; (b) NH2NH2.H2O, Acetic acid, reflux, 
14h; (c) 2-bromoethyl acetate, K2CO3, DMF, 12h; (d) LiOH. H2O, THF, MeOH, H2O, 14h; 
(e) Pyridine, reflux, 3 h; (f) Lawesson’s reagent, toluene, reflux, 8 h; (g) K3Fe(CN)6, 
aq.NaOH, EtOH, 90 °C, 2-3 h; (h) SnCl2.2H2O, EtOH, 3 h; (i) EDCI/HOBT, DCM, 14-16h. 
Conclusions 
In conclusion, a series consisting of 10 analogs have been synthesized by conjugating 
with biologically active heterocyclic scaffold 2-phenylbenzothiazole with chalcone and 
pyrazoline. The synthesized hybrids were decorated with diverse array of substituents on 2-
phenyl benzothiazoles to deduce the structure activity relationship (SAR). These conjugates 
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were tested for their anticancer potential against a panel of five different human cancer cell 
lines. Compounds 16a was found to be the most effective hybrid from the series displaying 
IC50 value of 0.25 ± 0.01 μM against the lung cancer cell line A549. Further studies to probe 
the mode of action of this conjugate are under progress. Moreover another two promising 
compounds 15a and 15b have shown potent cytotoxicity in B16 cells at 1.29 µM and 1.12 
µM. 
Statement of Problem 
Chapter IV: New Quinoline Linked Chalcone and Pyrazoline Conjugates: Molecular 
Properties Prediction, Antimicrobial and Antitubercular Activities. 
The quinoline nucleus is an important heterocyclic structure found in several natural 
and synthetic products with a wide range of pharmacological activities such as anti-
tuberculosis, antimalarial,
 
anti-inflammatory, anticancer, antibiotic, anti-hypertensive, and 
anti-HIV functions. Fluoroquinolones, such as gatifloxcin and moxifloxacin, target DNA 
topoisomerase IV and DNA gyrase and can be used as anti-TB agents, however, they often 
suffer from resistance. Quinoline-based anti-TB compound (TMC207), bearing a bulky biaryl 
side chain at position C3 is a highly potent anti-TB agent and is currently in phase II clinical 
trials. On the other hand, chalcones, which are important class of natural compounds, have 
been reported to possess diverse and interesting biological properties such as antioxidant, 
antifungal, antitumor, analgesic, anti-tuberculosis and anti-HIV. In addition, there have been 
numerous reports on the synthesis of pyrazoline derivatives owing to their wide ranging 
biological activities and their associated therapeutic potential as anti-HIV, anti-inflammatory, 
anticancer and anti-microbial agents. Therefore, considering the antimicrobial potential of 
quinoline, chalcone and pyrazoline derivatives we have developed a new structural motif 
containing all these structures to find potent antimicrobial agents. In the present investigation, 
two new series comprising of forty three conjugates (5a-j, 6a-i, 7a-d, 8b-f, 9a-f, 10a-d and 
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Scheme: Synthesis of quinoline linked chalcone and pyrazoline conjugates 
 
 
Reagents and conditions: (a) CH3CN, dil. HCl, 3 h, 79-81%; (b) EtOH, KOH, rt, 3 h, 80-
93%; (c) N2H4.H2O, EtOH, 8 h , reflux, 71-83%; (d) N2H4.H2O, AcOH, 8 h, reflux, 77-83%. 
Results and discussions 
All the synthesized conjugates were tested for their antibacterial, antifungal and 
antitubercular activities. It is important to note that some of these compounds such as 5e, 5f, 
5i, 5j, 7a, 8b, 8c, 8e, 8f, 11b and 11c showed potent antibacterial effects against both Gram 
positive and Gram negative pathogenic strains to variable extents. The conjugates 5j and 8b 
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demonstrated excellent antibacterial activity with the MIC values ranging from 4-8 µg/mL 
against the Gram positive bacterial strains. The active compounds 5j and 8b showed very 
good inhibitory zone at 20 µg/mL concentration when compared to standard reference drugs. 
Moreover MIC values of antifungal activity showed similar trend as antibacterial activity. 
Compound 5j was found to be the most promising candidate among the tested conjugates 




In conclusion two new series comprising of forty two compounds have been 
conveniently synthesized by linking the quinoline scaffold with the chalcone, pyrazoline 
moieties and evaluated them for prediction of their molecular properties through online 
software in order to find suitable molecules for the antitubercular, antimicrobial and 
antifungal activities with anticipation of generating new structural leads serving as potent 
anti-infective agents. Some of these compounds exhibited appreciable antibacterial activity 
against the tested bacterial strains. Compounds 5j and 8b were found to be the promising 
candidates exhibiting MIC 4 µg/mL against B. subtilis MTCC 121 and M. luteus MTCC 
2470. In addition, several compounds showed good inhibition of certain fungal organisms. 
Further, some of the compounds displayed good to appreciable anti-tubercular activity 
against both H37RV as well as Rif
R
 strains. Moreover several potent compounds were 
evaluated for their cytotoxic effect in MRC-5 Lung fibroblast cells and results of this study 
demonstrated that active compounds showed relatively low level of cytotoxicity. Selectivity 
index value for compound 5j was ≥5 which indicated that promising antitubercular 
compound. 
The binding modes and effect of the C4 quinoline substitution on the activity have been 
studied using molecular modeling. Methyl group was found to be more suitable than the 
aromatic phenyl group which was supported by the antimicrobial activity data. Therefore, 
compounds such as 5j and 8b could be considered as potential leads to generate chemical 
libraries that aid the process of development of newer antimicrobial agents to combat 
antibiotic resistance. 
 
